Table 5.
Bivariate and multivariate analyses of hypertensive patients attending at the chronic follow-up clinic at Northwest Ethiopia referral hospitals.
| Variables | CKD | COR | AOR | |
|---|---|---|---|---|
| Yes | No | |||
| SBP | ||||
| <140 mmHg | 65 | 452 | 1 | 1 |
| ≥140 mmHg | 37 | 27 | 9.529 (5.44, 16.68) | 1.72 (0.57, 5.21) |
|
| ||||
| DBP | ||||
| <90 mmHg | 71 | 456 | 1 | 1 |
| ≥90 mmHg | 31 | 23 | 8.656 (4.77, 15.68) | 8.65 (4.77, 15.68) |
|
| ||||
| Stage of HTN | ||||
| Stage I | 9 | 253 | 1 | 1 |
| Stage II | 82 | 206 | 11.19 (5.48, 22.81) | 2.61 (1.04, 6.50) |
| Stage III | 11 | 20 | 15.46 (5.73, 42.67) | 1.18 (0.26, 5.39) |
|
| ||||
| Duration of hypertension | ||||
| <10 years | 86 | 464 | 1 | 1 |
| ≥10 years | 16 | 15 | 5.75 (2.74, 12.07) | 8.81 (2.47, 31.45) |
|
| ||||
| Comorbid disease | ||||
| No | 91 | 130 | 1 | 1 |
| Yes | 11 | 349 | 22.20 (11.51, 42.8) | 7.0 (2.20, 22.21) |
|
| ||||
| Drugs other than HTN | ||||
| No | 26 | 347 | 1 | |
| Yes | 76 | 132 | 7.64 (4.71, 12.52) | 0.39 (0.14, 1.13) |
|
| ||||
| Proteinuria | ||||
| No | 43 | 445 | 1 | 1 |
| Yes | 59 | 34 | 17.95 (10.61, 30.37) | 4.59 (2.08, 10.12) |
|
| ||||
| Dyslipidemia | ||||
| No | 27 | 409 | 1 | 1 |
| Yes | 75 | 70 | 16.23 (9.76, 26.96) | 3.40 (1.56, 7.24) |
|
| ||||
| Serum creatinine | ||||
| <1 mg/dl | 29 | 434 | 1 | 1 |
| >1 mg/dl | 73 | 45 | 24.27 (14.31, 34.18) | 8.88 (4.40, 17.91) |